OMEPRAZOLE EXTENDED
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded a contract to DMS Pharmaceutical Group Inc under solicitation SPE2DP26F4853, with an award date of April 22, 2026, for the provision of OMEPRAZOLE EXTENDED, identified by NSN 6505016247068. This award is issued as a delivery order under the parent contract SPE2DX25D9900, and the total contract value is specified in the award documentation. The product is intended for federal use, with performance expected to occur within the United States under the authority of the Department of Defense. The contract was posted publicly on DIBBS on July 21, 2026, and no specific set aside classification or NAICS code is listed. All administrative details, including the point of contact and formal address information, are pending or not provided in the posted record.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(3)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
